This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

reputable news agency


Testosterone efficacious for correcting anemia in middle-aged men

Testosterone efficacious for correcting anemia in middle-aged men

Testosterone replacement therapy (TRT) is efficacious for correcting anemia among middle-aged and older men with hypogonadism and anemia, according to a study published online Oct. 27 in JAMA Network Open.

Karol M. Pencina, Ph.D., from Brigham and Women's Hospital in Boston, and colleagues examined the efficacy of TRT for correcting anemia in men with hypogonadism and anemia in a placebo-controlled trial conducted at 316 U.S. sites. A total of 5,204 eligible men aged 45 to 80 years with hypogonadal symptoms and cardiovascular disease or increased risk were included: 815 with anemia and 4,379 without anemia.

The researchers found that compared with placebo-treated men, a significantly greater proportion of testosterone-treated men had corrected anemia at six months (41.0 versus 27.5 percent), 12 months (45.0 versus 33.9 percent), 24 months (42.8 versus 30.9 percent), 36 months (43.5 versus 33.2 percent), and 48 months (44.6 versus 39.2 percent). A significantly smaller proportion of testosterone- versus placebo-treated men developed anemia among the participants without anemia. There was an association seen for changes in hemoglobin with changes in energy level.

"In middle-aged and with hypogonadism and anemia, TRT was more efficacious than placebo in correcting anemia," the authors write. "TRT was also associated with a reduced incidence of anemia among men without anemia at baseline."

Several authors disclosed ties to the ; one author reported holding a patent for a free testosterone calculator.

More information: Karol M. Pencina et al, Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism, JAMA Network Open (2023). DOI: 10.1001/jamanetworkopen.2023.40030

Shabbir M. H. Alibhai, Testosterone Replacement in Men With Hypogonadism and Effects on Anemia—Blood, Sex, and Aging, JAMA Network Open (2023). DOI: 10.1001/jamanetworkopen.2023.39969

Journal information: JAMA Network Open

Copyright © 2023 HealthDay. All rights reserved.

Citation: Testosterone efficacious for correcting anemia in middle-aged men (2023, October 30) retrieved 25 May 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Interleukin-1β inhibition linked to reduced incidence of anemia


Feedback to editors